• Streamlined, scalable, and automated workflow—from sample to answer
• Complete bioinformatics solution
• Unrivaled customer support you won't find elsewhere, with valuable services such as analytical validation
As precision oncology advances, it is increasingly important for molecular research to be carried out rapidly and efficiently. A multi-format test can provide the most information in the shortest time, helping to keep your research on pace. Using Oncomine Solutions, you can conduct a range of clinical oncology research protocols with one instrument in a single, end-to-end verified workflow.
Oncomine Solutions provides targeted and pan-cancer assays for biomarker testing from FFPE tissue and blood samples. In addition to initial biomarker testing, liquid biopsy can be used for monitoring tumor heterogeneity, and the detection of cancer progression. For immuno-oncology research, Tumor Mutation Burden (TMB) quantitative assays can enable patient selection and stratification. Oncomine Solutions is one suite of tools for all your research needs.
Oncomine Solutions are powered by the Ion Torrent GeneStudio System, a suite of benchtop sequencers that adapt to your sample type and frequency requirements. Multiple throughputs using your choice of five assay chips means your lab operates with maximum flexibility, without reagent waste – just pick the chip that meets your needs.
With the Ion Chef Instrument for automated sample preparation, and a complete bioinformatics workflow that includes reporting, Oncomine Solutions provides a truly integrated workflow—all from one supplier. Plus, our line of products is optimized and validated to work together seamlessly for a simplified NGS experience.
With Oncomine Solutions, you get a streamlined bioinformatics analysis pipeline optimized for each Oncomine assay—all packaged in a user-friendly experience.
The Oncomine Reporter delivers clear and concise reports that presents all relevant variants with information about targeted therapies, guidelines, and enrollment in ongoing clinical trials.
The report format is fully customizable, allowing you to easily develop a solution fit for your and your team's needs.
The Oncomine assay content is composed of key cancer driver gene variants. These can include mutations in EGFR (L858R, T790M and Exon 19 deletions), BRAF, KRAS, ERBB2, and MET, fusions involving ALK, ROS1, RET, and NTRK1/2/3, and many other alterations relevant to clinical oncology research.
The content is selected based on information in the Oncomine Knowledgebase, one of the world’s largest collections of curated oncology data, and confirmed with industry-leading pharmaceutical partners.
A team of dedicated Oncomine Solutions Applications Specialists ensures you always have answers when you need them. Working with you, our team can analyse your laboratory’s needs, establish the right solution, provide a real-time practical demonstration, and train your staff. And our support doesn’t end after implementation. We are always just a phone call away, whether you need to start a new application, have questions about the informatics, need support for accreditation, or anything else.
As part of our end-to-end commitment, we can also provide Analytical Validation (AV) services – technical project management of your lab’s AV to help verify that assays meet required parameters. This includes development and optimization of your validation workflow, data analysis support, and template documentation to fully maximize your instrument and reagent investment.
On average, we can help you complete the validation process 62–75% faster than without support; and by supplying control samples, data analysis, and reporting, we can help reduce your analytical validation costs by up to 50%.
For Research Use Only. Not for use in diagnostic procedures.